Please login to the form below

Not currently logged in
Email:
Password:

Javlor

This page shows the latest Javlor news and features for those working in and with pharma, biotech and healthcare.

NICE rejects Pierre Fabre's bladder cancer drug Javlor

NICE rejects Pierre Fabre's bladder cancer drug Javlor

NICE rejects Pierre Fabre's bladder cancer drug Javlor. Says drug received final draft 'no' because pharma company failed to prove efficacy. ... But having done so NICE nevertheless decided Javlor's high cost and 'inconclusive evidence' meant it couldn't

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
WCG

WCG is an independent, global agency specialising in healthcare communications. Our value as a company is about being the positive...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics